Newsroom
Sorted by: Latest
-
Charles Schwab Investment Management, Inc. UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Charles Schwab Investment Management, Inc. (CSIM) in its capacity as investment advisor to clients. CSIM expressly disclaims beneficial ownership of the shares described in this form 8.3. (b) Owner or controller of interests and short positions...
-
Ras Al Khaimah Signs Landmark Friendship Agreement & 10 MoUs during Historic High-Level Tour of South China
RAS AL KHAIMAH, United Arab Emirates--(BUSINESS WIRE)--Ras Al Khaimah Signs Landmark Friendship Agreement & 10 MoUs during Historic High-Level Tour of South China...
-
Digitate Advances Agentic AIOps with ignio™ Hummingbird, Bringing Autonomous Action to IT Operations
SANTA CLARA, Calif.--(BUSINESS WIRE)--Digitate, a leader in Agentic AI for IT Operations (Agentic AIOps), today announced ignio™ Hummingbird, the latest release of its agentic AIOps platform. Hummingbird introduces AI agents that bring operational expertise to specific IT tasks, move from diagnosis through approved action and verification, and operate within enterprise change, approval and audit controls.The release also enables enterprises to build their own IT operations agents and includes bu...
-
Genmab Announces Statistically Significant, Clinically Meaningful Improvement in Overall Survival and Objective Response with Petosemtamab Combination at First Interim Analysis in First-Line R/M Patients with PD-L1+ Head and Neck Cancer
COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) today announced positive topline results from the global Phase 3 LiGeR-HN1 trial (NCT06525220) evaluating petosemtamab, an investigational IgG1-bispecific antibody targeting the epidermal growth factor receptor (EGFR) and the leucine-rich repeat containing G-protein-coupled receptor 5 (LGR5), in combination with pembrolizumab versus pembrolizumab in patients with first-line (1L) PD-L1 positive recurrent/metastatic head and neck squ...
-
AM Best to Join Life/Annuity Insurance-Focused Panel Discussion at Capitol Forum Event
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best will join a panel discussion to discuss shifting market forces in the U.S. life/annuity insurance segment at The Capitol Forum's “Life & Annuity Industry at a Crossroads” event, on Thursday, Nov. 12, 2026, at the National Press Club in Washington, D.C. Sridhar Manyem, senior director, industry research and analytics, AM Best, will speak on the panel, titled, “The New Life Insurance Business Model: From Conservatism to Complexity, How Life and Annuity...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...
-
Synthflow Launches Vector, a Long-Horizon AI Agent for Lenders That Doesn’t Stop When the Call Ends
BERLIN--(BUSINESS WIRE)--Synthflow, the Berlin-based voice AI provider, has launched Vector, a long horizon AI agent for consumer lenders that sees a loan application or an overdue account through to the finish, rather than stopping when the call ends. Vector is Synthflow’s first industry-specific agent. The company is expanding its portfolio to include agents designed for long-term use, complementing its general-purpose language automation solutions. The AI is trained for the detailed work of...
-
Schwab Advisor Services™ Expands AI Inside Schwab Advisor Center and Across the Third-Party Solutions RIAs Use
WESTLAKE, Texas & BOSTON--(BUSINESS WIRE)--Schwab Advisor Services, Charles Schwab's business supporting the growth and success of more than 17,000 independent registered investment advisors (RIAs), today announced new AI solutions for RIAs, available inside Schwab Advisor Center and through the third-party solutions that connect to it. The news was announced from Schwab IMPACT®, the largest and longest running annual event for RIAs and the ecosystem that serves them. “AI can and will play a ro...
-
QVT Issues Second Report on Jackson Financial (JXN) Subsidiary Brooke Life Reinsurance Co. Underscoring Near-Term Liquidity Challenges
NEW YORK--(BUSINESS WIRE)--QVT Financial LP ("QVT") today issued a second report on Jackson Financial, Inc. (NYSE: JXN), underscoring QVT’s concerns regarding the solvency of JXN’s subsidiary Brooke Life Reinsurance Co. (“Brooke Re”), and detailing its estimates that Brooke Re will face significant liquidity challenges in the coming quarters. In addition, the report addresses a new issue regarding potential significant overstatement of JXN’s adjusted operating earnings due to understatement of...
-
Netsmart Showcases Embedded AI and Automation Across its Intelligent Platform at the Alliance Annual 2026
OVERLAND PARK, Kan.--(BUSINESS WIRE)--Netsmart announces attendance at the National Alliance for Care at Home Annual Meeting & Exposition featuring its intelligent CareFabric platform....